Literature DB >> 16432447

Improved long-term outcome with long-acting risperidone treatment of chronic schizophrenia with prior partial response.

Jean-Pierre Lindenmayer1, Mohan Parak, Jack M Gorman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16432447     DOI： 10.1097/00131746-200601000-00009

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN： 1527-4160            Impact factor:   1.325


× No keyword cloud information.
  2 in total

1.  Long-acting injectable risperidone and metabolic ratio: a possible index of clinical outcome in treatment-resistant schizophrenic patients.

Authors:  Lucia Sara Volonteri; Giancarlo Cerveri; Ilaria Francesca De Gaspari; Maria Luisa Baldi; Maria Laura Rolandi; Pietro Papa; Massimo Carlo Mauri; Claudio Mencacci
Journal:  Psychopharmacology (Berl)       Date:  2010-04-27       Impact factor: 4.530

2.  Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America.

Authors:  Rogelio Apiquian; Rodrigo Córdoba; Mario Louzã
Journal:  Neuropsychiatr Dis Treat       Date:  2010-12-22       Impact factor: 2.570
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.